Investigational Whooping Cough Vaccine
Research area: Infection, Immunity and Global Health > Vaccine & Immunisation Research Group (VIRGo) | Status: Active
A whooping cough study from Vaccine & Immunisation Research Group (VIRGo) using BPZE1 (intranasal vaccine)
We are looking for school-aged children six to 17 years to take part in a clinical research study looking at the effectiveness of an experimental pertussis (whooping cough) vaccine, given as a fine spray into the nose.
We are looking for school-aged children six to 17 years to take part in a clinical research study looking at the effectiveness of an experimental pertussis (whooping cough) vaccine, given as a fine spray into the nose.
Overview
Pertussis is an illness often known as “whooping cough” and is an infection in the upper airway and the lungs. This is a serious infection that is easily passed to others (it’s very contagious). The effects of this infection can last up to 100 days.
Current vaccines provide protection against severe whooping cough but are less good at protecting against mild infection and preventing the spread of whooping cough.
The study will compare the experimental nasal spray vaccine with a licensed vaccine (BoostrixTM) that protects against tetanus, diphtheria and pertussis.
Information for participants
Participation will last for about six months and will include visits to the clinic and phone calls to check your health.
Reimbursement will be provided for travel and for your time.
To find out more and check if your child is eligible to participate, check out Super Trial or contact us below:
Contact us
Vaccine and Immunisation Research Group (VIRGo)
Murdoch Children's Research Institute
The Royal Children's Hospital
50 Flemington Road
Parkville VIC 3052
Australia
Phone: show phone number
Email: [email protected]
Vaccination newsroom
Study into rare side effects of COVID-19 vaccines
A new international study will examine the rare side effects caused by COVID-19 vaccines to...
Fractional COVID-19 booster vaccines produce similar immune response as full-doses
Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response...
Victorian government accelerates vaccine uptake, mental health and genetic disease programs
Murdoch Children’s Research Institute Doctors Carmen Pace, Jessica Kaufman, and Simone...
Health institutions applaud $620M injection for strong and resilient health systems in the Pacific and Southeast Asia
An alliance of Australia’s leading health and development institutions, including Murdoch...
Social media surveillance by artificial intelligence improves detection of vaccine adverse events
The use of Artificial Intelligence (AI) in surveillance of social media conversations improves...
COVID-19 and influenza maternal vaccine study receives funding
A world-first Murdoch Children’s Research Institute GenV project has secured State Government...
Championing the vaccine cause in the Pacific
When it comes to vaccinations, Australians are prepared to roll up their sleeves.
Australia is a...
Share //
